Benjamin Edwards Inc. Sells 12,654 Shares of iShares Biotechnology ETF $IBB

Benjamin Edwards Inc. lessened its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 79.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,231 shares of the financial services provider’s stock after selling 12,654 shares during the period. Benjamin Edwards Inc.’s holdings in iShares Biotechnology ETF were worth $614,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in IBB. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the 2nd quarter worth about $25,000. Basepoint Wealth LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $26,000. Pension & Wealth Management Advisors Inc. purchased a new stake in iShares Biotechnology ETF during the second quarter valued at about $28,000. Cary Street Partners Financial LLC bought a new position in iShares Biotechnology ETF during the fourth quarter worth about $29,000. Finally, Copia Wealth Management bought a new position in iShares Biotechnology ETF during the fourth quarter worth about $34,000. Institutional investors own 62.45% of the company’s stock.

Get iShares Biotechnology ETF alerts:

iShares Biotechnology ETF Trading Up 1.4%

IBB opened at $213.80 on Thursday. The firm has a 50-day moving average price of $196.95 and a 200-day moving average price of $179.74. iShares Biotechnology ETF has a twelve month low of $138.79 and a twelve month high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a yield of 0.0%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More

• Five stocks we like better than iShares Biotechnology ETF
• Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
• J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
• Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
• GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.